• Debate at CSANZ if plaque volume analysis is ready for prime time. Evidence is limited but Heart Flow is offering it.Asked AI for some references!
  • Multimodality imaging of tricuspid valve. Presentation at CSANZ 2025- this is AI generated information relating to publications by the presenter.
  • Updated 2025 guidelines on assessment of diastolic function. Reference one and two with AI
  • After CSANZ meeting and session attendance searched for articles on athletes and RV disease.
  • Aortic stenosis- recent trials in asymptomatic patients.Searched after session at CSANZ 2025.
  • Pericardial constriction and tamponade
  • Aortic stenosis. Functional assessment of coronary stenosis severity. Abstract
  • Schulze, K., Stantien, AM., Williams, M.C. et al. Coronary CT angiography evaluation with artificial intelligence for individualized medical treatment of atherosclerosis: a Consensus Statement from the QCI Study Group. Nat Rev Cardiol (2025).


  • Tricuspid valve publications. Search Gemini during CSANZ 2025.
  • CYP2C19 Genotype and Clopidogrel Therapy
    2022 Update, Clinical Pharmacogenetics Implementation Consortium Guideline
  • Colchicine in Pericarditis
  • Invasive Treatment Strategy for Older Patients with Myocardial Infarction
    Ischaemic Heart Disease: NSTEMI.
  • Long-term survival after transcatheter aortic valve implantation.
    Nationwide Danish Cohort Study
  • Oral Semaglutide in an East Asian population
    With overweight or obesity, with or without Type 2 diabetes
  • Intravenous Iodinated Contrast Use in Cardiac Computed Tomography Angiography.